In a manuscript published in July of 2011, Saidpour et al.1 reported beneficial effects of fish oil and olive oil on insulin resistance after an eight-week intervention in rats. Fish oil is a rich source of n-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).2 There is evidence for the role of n-3 fatty acids in insulin resistance and diabetes, as other studies have shown similar effects of fish oil on insulin resistance in obese rats2 as well as in humans.3 Furthermore, according to a recent study, omega-3 supplementation in diabetic patients results in increased visfatin levels,4 although evidence is controversial regarding visfatin and its function. While visfatin is an inflammatory factor and higher levels may have adverse effects,4 omega-3 fatty acids help prevent glucose intolerance and have anti-inflammatory properties.5 Another question that is still open to debate relates to the dietary source of omega-3 fatty acids. EPA and DHA are long chain polyunsaturated fatty acids (LCPUFA) found in fish and other animal sources whereas α-linolenic acid (ALA) comes from vegetable sources. Although there is no indication of a significant association between the marine source of omega-3 fatty acids and diabetes risk, an inverse significant relationship has been observed between non-marine omega-3 fatty acid intake and diabetes incidence in an Asian cohort that studied high marine foods consumption.6 Nonetheless, a beneficial association between fish intake and diabetes risk was found in another cohort study of men.7 In contrast, a 12.4-year cohort study indicated a positive association between marine omega-3 fatty acid and type 2 diabetes incidence in women.8 These conflicting results are not restricted to only diabetes. A cohort study with 23-year follow-up found a significant inverse association between LCPUFA (not ALA) intake and risk of ischemic heart disease.9 Conversely, a recent study reported a favorable association between dietary intake of total omega-3 fatty acids and risk of inflammatory disease mortality.10 However, further analyses suggested nuts had preventive properties against inflammatory disease mortality, but fish did not.10 When attempting to understand inconsistencies across studies, some points should be noted. First, contaminants of marine foods may play a role.11 Second, the amount of fish consumption in the population studied is important. For intervention studies, the dose of supplementation and the intake of dietary fish oil or other dietary sources of omega-3 fatty acids must be considered. Finally, the susceptibility of omega-3 to oxidation may also play a role, such that the antioxidant intake may affect the association between omega-3 fatty acids and diabetes or other chronic diseases.12
On the other hand, an improved postprandial insulin response has been reported due to olive oil consumption in insulin resistant women.13 However, the components of all olive oils are not the same which could partially account for different effects.14 Dietary approaches to stop hypertension (DASH), a source of good dietary fat -limited in saturated fatty acids- and full of fiber, has been shown to have anti-diabetic, anti-hyperlipidemic and anti-inflammation properties in recent studies.15,16
Further research is needed to understand the role of omega-3 fatty acids on insulin resistance and risk of diabetes. However, olive oil consumption may exert beneficial effects on the diets of diabetic patients.
Authors’ Contributions
LA, MHR, and PJS wrote this letter.
Footnotes
Conflict of Interests Authors have no conflict of interests.
References
- 1.Saidpour A, Zahediasl S, Kimiagar M, Vafa M, Ghasemi A, Abadi A, et al. Fish oil and olive oil can modify insulin resistance and plasma desacyl-ghrelin in rats. J Res Med Sci. 2011;16(7):862–71. [PMC free article] [PubMed] [Google Scholar]
- 2.Yamazaki RK, Brito GA, Coelho I, Pequitto DC, Yamaguchi AA, Borghetti G, et al. Low fish oil intake improves insulin sensitivity, lipid profile and muscle metabolism on insulin resistant MSG-obese rats. Lipids Health Dis. 2011;10:66. doi: 10.1186/1476-511X-10-66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ramel A, Martinez A, Kiely M, Morais G, Bandarra NM, Thorsdottir I. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia. 2008;51(7):1261–8. doi: 10.1007/s00125-008-1035-7. [DOI] [PubMed] [Google Scholar]
- 4.Hajianfar H, Hosseinzadeh MJ, Bahonar A, Mohammad K, Askari GR, Entezari MH, et al. The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes. J Res Med Sci. 2011;16(4):490–5. [PMC free article] [PubMed] [Google Scholar]
- 5.Eguchi R, Scarmagnani FR, Cunha CA, Souza GI, Pisani LP, Ribeiro EB, et al. Fish oil consumption prevents glucose intolerance and hypercorticosteronemy in footshock-stressed rats. Lipids Health Dis. 2011;10:71. doi: 10.1186/1476-511X-10-71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Brostow DP, Odegaard AO, Koh WP, Duval S, Gross MD, Yuan JM, et al. Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2011;94(2):520–6. doi: 10.3945/ajcn.110.009357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Nanri A, Mizoue T, Noda M, Takahashi Y, Matsushita Y, Poudel-Tandukar K, et al. Fish intake and type 2 diabetes in Japanese men and women: the Japan Public Health Center-based Prospective Study. Am J Clin Nutr. 2011;94(3):884–91. doi: 10.3945/ajcn.111.012252. [DOI] [PubMed] [Google Scholar]
- 8.Djousse L, Gaziano JM, Buring JE, Lee IM. Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr. 2011;93(1):143–50. doi: 10.3945/ajcn.110.005603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Vedtofte MS, Jakobsen MU, Lauritzen L, Heitmann BL. Dietary {alpha}-linolenic acid, linoleic acid, and n-3 long-chain PUFA and risk of ischemic heart disease. Am J Clin Nutr. 2011;94(4):1097–103. doi: 10.3945/ajcn.111.018762. [DOI] [PubMed] [Google Scholar]
- 10.Gopinath B, Buyken AE, Flood VM, Empson M, Rochtchina E, Mitchell P. Consumption of polyunsaturated fatty acids, fish, and nuts and risk of inflammatory disease mortality. Am J Clin Nutr. 2011;93(5):1073–9. doi: 10.3945/ajcn.110.009977. [DOI] [PubMed] [Google Scholar]
- 11.Feskens EJ. The prevention of type 2 diabetes: should we recommend vegetable oils instead of fatty fish? Am J Clin Nutr. 2011;94(2):369–70. doi: 10.3945/ajcn.111.020172. [DOI] [PubMed] [Google Scholar]
- 12.Osterud B, Elvevoll EO. Dietary omega-3 fatty acids and risk of type 2 diabetes: lack of antioxidants? Am J Clin Nutr. 2011;94(2):617–8. doi: 10.3945/ajcn.111.017855. [DOI] [PubMed] [Google Scholar]
- 13.Farnetti S, Malandrino N, Luciani D, Gasbarrini G, Capristo E. Food fried in extra-virgin olive oil improves postprandial insulin response in obese, insulin-resistant women. J Med Food. 2011;14(3):316–21. doi: 10.1089/jmf.2009.0264. [DOI] [PubMed] [Google Scholar]
- 14.Wyler S. All olive oils are not the same. Am J Clin Nutr. 2011;94(1):288–90. doi: 10.3945/ajcn.111.016915. [DOI] [PubMed] [Google Scholar]
- 15.Azadbakht L, Surkan PJ, Esmaillzadeh A, Willett WC. The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. J Nutr. 2011;141(6):1083–8. doi: 10.3945/jn.110.136739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Azadbakht L, Fard NR, Karimi M, Baghaei MH, Surkan PJ, Rahimi M, et al. Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes Care. 2011;34(1):55–7. doi: 10.2337/dc10-0676. [DOI] [PMC free article] [PubMed] [Google Scholar]